118 related articles for article (PubMed ID: 17597697)
1. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats.
Mizobuchi M; Finch JL; Martin DR; Slatopolsky E
Kidney Int; 2007 Sep; 72(6):709-15. PubMed ID: 17597697
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor activators can protect against vascular calcification.
Mathew S; Lund RJ; Chaudhary LR; Geurs T; Hruska KA
J Am Soc Nephrol; 2008 Aug; 19(8):1509-19. PubMed ID: 18448587
[TBL] [Abstract][Full Text] [Related]
3. The comparison of paricalcitol and calcitriol effects on pulse wave velocity, osteocalcin, and fetuin-A in chronic hemodialysis patients.
Karakose S; Bal Z; Sezer S
Semin Dial; 2024; 37(2):131-137. PubMed ID: 37392044
[TBL] [Abstract][Full Text] [Related]
4. THE EFFECT OF PARICALCITOL AND CALCITRIOL WITH OR WITHOUT CALCIMIMETICS ON PULSE WAVE VELOCITY AND SERUM LEVELS FOR PARATHYROID HORMONE, CALCIUM AND PHOSPHORUS IN MAINTENANCE HEMODIALYSIS PATIENTS.
Bal AZ; Bal U; Akdogan M; Sezer S
Acta Endocrinol (Buchar); 2023; 19(4):480-486. PubMed ID: 38933256
[TBL] [Abstract][Full Text] [Related]
5. Myocardial effects of VDR activators in renal failure.
Mizobuchi M; Nakamura H; Tokumoto M; Finch J; Morrissey J; Liapis H; Slatopolsky E
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):188-92. PubMed ID: 20236614
[TBL] [Abstract][Full Text] [Related]
6. Impact of post-dialysis calcium level on ex vivo rat aortic wall calcification.
Azpiazu D; González-Parra E; Ortiz A; Egido J; Villa-Bellosta R
PLoS One; 2017; 12(8):e0183730. PubMed ID: 28832652
[TBL] [Abstract][Full Text] [Related]
7. Vitamin d receptor activators and clinical outcomes in chronic kidney disease.
Gravellone L; Rizzo MA; Martina V; Mezzina N; Regalia A; Gallieni M
Int J Nephrol; 2011; 2011():419524. PubMed ID: 21647319
[TBL] [Abstract][Full Text] [Related]
8. High-phosphate-induced calcification is related to SM22α promoter methylation in vascular smooth muscle cells.
Montes de Oca A; Madueño JA; Martinez-Moreno JM; Guerrero F; Muñoz-Castañeda J; Rodriguez-Ortiz ME; Mendoza FJ; Almaden Y; Lopez I; Rodriguez M; Aguilera-Tejero E
J Bone Miner Res; 2010 Sep; 25(9):1996-2005. PubMed ID: 20499380
[TBL] [Abstract][Full Text] [Related]
9. Restoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats.
De Schutter TM; Behets GJ; Jung S; Neven E; D'Haese PC; Querfeld U
Calcif Tissue Int; 2012 Nov; 91(5):307-15. PubMed ID: 22926202
[TBL] [Abstract][Full Text] [Related]
10. Significance of the Vitamin D Receptor on Crosstalk with Nuclear Receptors and Regulation of Enzymes and Transporters.
Noh K; Chow ECY; Quach HP; Groothuis GMM; Tirona RG; Pang KS
AAPS J; 2022 Jun; 24(4):71. PubMed ID: 35650371
[TBL] [Abstract][Full Text] [Related]
11. The Calcified Vasculature in Chronic Kidney Disease Secretes Factors that Inhibit Bone Mineralization.
Mace ML; Gravesen E; Nordholm A; Egstrand S; Morevati M; Olgaard K; Lewin E
JBMR Plus; 2022 Apr; 6(4):e10610. PubMed ID: 35434452
[TBL] [Abstract][Full Text] [Related]
12. Recovery of limb perfusion and function after hindlimb ischemia is impaired by arterial calcification.
Zettervall SL; Wang XL; Monk S; Lin T; Cai Y; Guzman RJ
Physiol Rep; 2021 Aug; 9(16):e15008. PubMed ID: 34405571
[TBL] [Abstract][Full Text] [Related]
13. Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects.
Bover J; Aguilar A; Arana C; Molina P; Lloret MJ; Ochoa J; Berná G; Gutiérrez-Maza YG; Rodrigues N; D'Marco L; Górriz JL
Front Med (Lausanne); 2021; 8():642718. PubMed ID: 34095165
[TBL] [Abstract][Full Text] [Related]
14. Impaired arterial vitamin D signaling occurs in the development of vascular calcification.
Lim K; Molostvov G; Lubczanska M; Fletcher S; Bland R; Hiemstra TF; Zehnder D
PLoS One; 2020; 15(11):e0241976. PubMed ID: 33211721
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Analogues and Coronary Calcification in CKD Stages 3 and 4: A Randomized Controlled Trial of Calcitriol Versus Paricalcitol.
Anis KH; Pober D; Rosas SE
Kidney Med; 2020; 2(4):450-458. PubMed ID: 32775985
[TBL] [Abstract][Full Text] [Related]
16. PTH suppression by calcitriol does not predict off-target actions in experimental CKD.
Svajger BA; Pruss CM; Laverty KJ; Zelt JGE; Jones G; Kaufmann M; Petkovich M; Holden RM; Adams MA
Pharmacol Res Perspect; 2020 Jun; 8(3):e00605. PubMed ID: 32519465
[TBL] [Abstract][Full Text] [Related]
17. Hyperphosphatemia and Chronic Kidney Disease: A Major Daily Concern Both in Adults and in Children.
Bacchetta J; Bernardor J; Garnier C; Naud C; Ranchin B
Calcif Tissue Int; 2021 Jan; 108(1):116-127. PubMed ID: 31996964
[TBL] [Abstract][Full Text] [Related]
18. New Insights into the Roles of Monocytes/Macrophages in Cardiovascular Calcification Associated with Chronic Kidney Disease.
Hénaut L; Candellier A; Boudot C; Grissi M; Mentaverri R; Choukroun G; Brazier M; Kamel S; Massy ZA
Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31547340
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
